Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO2221 | Lophozia lycopodioides | Species | Scapaniaceae | Eukaryota | UNPD* | |||
NPO12856 | Kadsura induta | Species | Schisandraceae | Eukaryota | UNPD* | |||
NPO13391 | Streptomyces hygroscopicus | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO6258 | Streptomyces tubercidicus | Species | Streptomycetaceae | Bacteria | StreptomeDB* | |||
NPO10847 | Randia longiflora | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO408 | Garcinia dioica | Species | Clusiaceae | Eukaryota | UNPD* | |||
NPO7585 | Narvalina domingensis | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO12969 | Phyllosticta hydrangeae | Species | Phyllostictaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 0.007 | ug/ml | 6699874 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | = | 0.2 | ug/ml | 6699874 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC | = | 0.007 | ug/ml | 6699874 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | = | 0.07 | ug/ml | 6699874 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC | = | 0.07 | ug/ml | 6699874 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | = | 0.2 | ug/ml | 6699874 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | = | 0.07 | ug/ml | 6699874 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | = | 0.2 | ug/ml | 6699874 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.02 | ug/ml | 6699874 |
NPT137 | Cell Line | L1210 | Mus musculus | ID50 | = | 0.04 | ug/ml | 6699874 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC50 | = | 0.1 | ug/ml | 3820218 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC50 | = | 0.1 | ug/ml | 3820218 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC50 | = | 0.007 | ug/ml | 3820218 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | = | 0.02 | ug/ml | 3820218 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC50 | = | 0.01 | ug/ml | 3820218 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC50 | = | 0.07 | ug/ml | 3820218 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC50 | = | 0.02 | ug/ml | 3820218 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC50 | = | 0.04 | ug/ml | 3820218 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC50 | = | 0.07 | ug/ml | 3820218 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC50 | = | 0.2 | ug/ml | 3820218 |
NPT1049 | Organism | Measles virus | Measles virus | MIC50 | = | 0.3 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.04 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 5.4 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.29 | ug/ml | 3820218 |
NPT137 | Cell Line | L1210 | Mus musculus | MIC50 | = | 0.173 | ug/ml | 3820218 |
NPT1171 | Cell Line | HEp-2 | Homo sapiens | IC50 | = | 2 | nM | 6708054 |
NPT1171 | Cell Line | HEp-2 | Homo sapiens | IC50 | > | 3000 | nM | 6708054 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | >= | 0.4 | ug/ml | 3027326 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | >= | 0.4 | ug/ml | 3027326 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.07 | ug/ml | 3027326 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 200 | ug/ml | 3027326 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.07 | ug/ml | 2540332 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC | = | 0.07 | ug/ml | 2540332 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC | = | 0.07 | ug/ml | 2540332 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | = | 0.1 | ug/ml | 2540332 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | = | 0.07 | ug/ml | 2540332 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC | > | 0.4 | ug/ml | 2540332 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 0.018 | ug/ml | 6538600 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 67.7 | nM | 6538600 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 500 | nM | 8254613 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 400 | nM | 8254613 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 43 | nM | 8254613 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 60 | nM | 8254613 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 100 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 92 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 16 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 10 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 11 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 80 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 9 | % | 7783159 |
NPT4408 | Cell Line | CHO-K1-BH4 | Cricetulus griseus | Inhibition | = | 4 | % | 7783159 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | > | 0.2 | ug/ml | 1335077 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | = | 0.2 | ug/ml | 1335077 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | > | 0.1 | ug/ml | 1335077 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 0.07 | ug/ml | 1335077 |
NPT1106 | Organism | Human poliovirus 1 | Human poliovirus 1 | MIC | = | 0.2 | ug/ml | 1335077 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | = | 0.2 | ug/ml | 1335077 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | = | 0.07 | ug/ml | 1335077 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC | = | 0.02 | ug/ml | 1335077 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | = | 0.02 | ug/ml | 1335077 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | > | 0.1 | ug/ml | 1335077 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC | > | 0.1 | ug/ml | 1335077 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 500 | nM | 2846837 |
NPT859 | Cell Line | HFF | Homo sapiens | IC50 | = | 400 | nM | 2846837 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 43 | nM | 9057866 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.1 | ug/ml | 2754698 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 0.07 | ug/ml | 2754698 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC | = | 0.07 | ug/ml | 2754698 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC | = | 0.4 | ug/ml | 2754698 |
NPT336 | Organism | Human parainfluenza virus 3 | Human parainfluenza virus 3 | MIC | > | 0.1 | ug/ml | 2754698 |
NPT2602 | Organism | Mammalian orthoreovirus 1 | Mammalian orthoreovirus 1 | MIC | > | 0.1 | ug/ml | 2754698 |
NPT338 | Organism | Sindbis virus | Sindbis virus | MIC | = | 0.2 | ug/ml | 2754698 |
NPT335 | Organism | Human coxsackievirus B4 | Human coxsackievirus B4 | MIC | > | 0.1 | ug/ml | 2754698 |
NPT856 | Organism | Semliki forest virus | Semliki forest virus | MIC | > | 0.1 | ug/ml | 2754698 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 40 | nM | 2913300 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 500 | nM | 2913300 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | > | 0.4 | ug/ml | 2552118 |
NPT1141 | Organism | Human herpesvirus 2 | Human herpesvirus 2 | MIC | > | 0.4 | ug/ml | 2552118 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | > | 0.1 | ug/ml | 2552118 |
NPT195 | Organism | Vesicular stomatitis virus | Vesicular stomatitis virus | MIC | = | 0.2 | ug/ml | 2552118 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.2 | ug/ml | 2552118 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.02 | ug/ml | 2552118 |
NPT334 | Organism | Vaccinia virus | Vaccinia virus | MIC | = | 0.07 | ug/ml | 2552118 |
NPT168 | Cell Line | P388 | Mus musculus | ID50 | = | 3.8 | nM | 2641872 |
NPT137 | Cell Line | L1210 | Mus musculus | ID50 | = | 5.4 | nM | 2641872 |
NPT116 | Cell Line | HL-60 | Homo sapiens | ID50 | = | 1.00E-09 | nM | 2641872 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | MIC | > | 0.4 | ug/ml | 3585910 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | MIC | = | 0.2 | ug/ml | 3585910 |
NPT419 | Organism | Oryctolagus cuniculus | Oryctolagus cuniculus | MIC | = | 0.07 | ug/ml | 3585910 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC | = | 0.07 | ug/ml | 3585910 |
NPT165 | Cell Line | HeLa | Homo sapiens | MIC | = | 0.2 | ug/ml | 3585910 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC | = | 0.2 | ug/ml | 3585910 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC | > | 0.1 | ug/ml | 3585910 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | MIC | > | 0.4 | ug/ml | 3585910 |
NPT1374 | Cell Line | WI-38 | Homo sapiens | MIC | = | 0.02 | ug/ml | 3585910 |
NPT1374 | Cell Line | WI-38 | Homo sapiens | MIC | > | 4 | ug/ml | 3585910 |
NPT137 | Cell Line | L1210 | Mus musculus | IC50 | = | 40 | nM | 1310744 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 60 | nM | 1310744 |
NPT1750 | Organism | Human herpesvirus 5 | Human herpesvirus 5 | IC50 | = | 500 | nM | 1310744 |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 1000 | nM | 1310744 |
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | > | 100000 | nM | 7707320 |
NPT2603 | Individual Protein | Adenosine kinase | Homo sapiens | IC50 | = | 10000 | nM | 10956196 |
NPT2 | Others | Unspecified | Ki | = | 500 | nM | 17977728 | |
NPT2 | Others | Unspecified | Activity | = | 114 | 17977728 | ||
NPT1048 | Organism | Poliovirus | Human enterovirus C | IC50 | = | 30 | nM | 20964406 |
NPT2 | Others | Unspecified | EC50 | = | 204 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | < | 100 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | = | 252 | nM | PubChem BioAssay data set | |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 5044 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 1122 | nM | PubChem BioAssay data set |
NPT1415 | Individual Protein | Heat shock factor protein 1 | Mus musculus | EC50 | = | 3057 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 2438 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | = | 4118 | nM | PubChem BioAssay data set | |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 2082 | nM | PubChem BioAssay data set |
NPT531 | Individual Protein | Nuclear receptor ROR-gamma | Mus musculus | Potency | = | 631 | nM | PubChem BioAssay data set |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 5450 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | = | 223 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 9200 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 3662.6 | nM | PubChem BioAssay data set | |
NPT1415 | Individual Protein | Heat shock factor protein 1 | Mus musculus | AC50 | = | 10488 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | IC50 | = | 1010 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | > | 80000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 7420 | nM | PubChem BioAssay data set | |
NPT1415 | Individual Protein | Heat shock factor protein 1 | Mus musculus | AC50 | = | 3174 | nM | PubChem BioAssay data set |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 1 | nM | 21711054 |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | = | 11 | nM | 21711054 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 18 | nM | 21711054 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 48 | nM | 21711054 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | = | 1 | nM | 21711054 |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | = | 11 | nM | 21711054 |
NPT2 | Others | Unspecified | GI50 | = | 98 | nM | 21711054 | |
NPT25 | Cell Line | MT4 | Homo sapiens | GI50 | = | 21 | nM | 21711054 |
NPT15 | Cell Line | Jurkat | Homo sapiens | IC50 | = | 7830 | nM | PubChem BioAssay data set |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 100000 | nM | PubChem BioAssay data set | |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | 1000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 316.2 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 446.7 | nM | PubChem BioAssay data set | |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | < | 104 | nM | PubChem BioAssay data set |
NPT71 | Cell Line | HEK293 | Homo sapiens | Activity | > | 2.5 | nM | 21870828 |
NPT4409 | Individual Protein | Programmed cell death protein 4 | Homo sapiens | IC50 | = | 880 | nM | 21870828 |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 517.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1584.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 35481.3 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 651.3 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 3162.3 | nM | PubChem BioAssay data set | |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 1584.9 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 4.48 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | -12.3 | % | 23062825 |
NPT2 | Others | Unspecified | Potency | 819.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 145.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 20.6 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 651.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1412.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 2770 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 819.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 91.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 250 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 920 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 2511.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 3980 | nM | PubChem BioAssay data set | ||
NPT535 | Individual Protein | Parathyroid hormone receptor | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 580.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1778.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 1600 | nM | PubChem BioAssay data set | ||
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | 9200 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 651.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 28183.8 | nM | PubChem BioAssay data set | ||
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 28183.83 | nM | 27119979 |
NPT2604 | Individual Protein | Heat shock cognate 71 kDa protein | Homo sapiens | Kd | = | 28000 | nM | 27119979 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC125659 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC168702 |
0.9172 | High Similarity | NPC33382 |
0.9119 | High Similarity | NPC222174 |
0.7901 | Intermediate Similarity | NPC207633 |
0.75 | Intermediate Similarity | NPC239737 |
0.7471 | Intermediate Similarity | NPC321393 |
0.7469 | Intermediate Similarity | NPC21448 |
0.7469 | Intermediate Similarity | NPC156461 |
0.7469 | Intermediate Similarity | NPC107374 |
0.7426 | Intermediate Similarity | NPC107160 |
0.7423 | Intermediate Similarity | NPC164665 |
0.7423 | Intermediate Similarity | NPC189068 |
0.7378 | Intermediate Similarity | NPC269827 |
0.7378 | Intermediate Similarity | NPC219313 |
0.7378 | Intermediate Similarity | NPC309832 |
0.7346 | Intermediate Similarity | NPC229974 |
0.7222 | Intermediate Similarity | NPC209525 |
0.7222 | Intermediate Similarity | NPC161659 |
0.7202 | Intermediate Similarity | NPC211025 |
0.7202 | Intermediate Similarity | NPC185991 |
0.7202 | Intermediate Similarity | NPC85689 |
0.716 | Intermediate Similarity | NPC472816 |
0.716 | Intermediate Similarity | NPC321814 |
0.7143 | Intermediate Similarity | NPC150853 |
0.7134 | Intermediate Similarity | NPC314152 |
0.7118 | Intermediate Similarity | NPC130586 |
0.7118 | Intermediate Similarity | NPC164952 |
0.7118 | Intermediate Similarity | NPC302778 |
0.7118 | Intermediate Similarity | NPC212551 |
0.7117 | Intermediate Similarity | NPC317821 |
0.711 | Intermediate Similarity | NPC138018 |
0.7076 | Intermediate Similarity | NPC174802 |
0.7055 | Intermediate Similarity | NPC129756 |
0.7035 | Intermediate Similarity | NPC224076 |
0.7024 | Intermediate Similarity | NPC121222 |
0.6994 | Remote Similarity | NPC316618 |
0.6994 | Remote Similarity | NPC226245 |
0.6901 | Remote Similarity | NPC161224 |
0.6833 | Remote Similarity | NPC319456 |
0.6829 | Remote Similarity | NPC250178 |
0.68 | Remote Similarity | NPC311197 |
0.68 | Remote Similarity | NPC313754 |
0.68 | Remote Similarity | NPC54320 |
0.6798 | Remote Similarity | NPC323091 |
0.6788 | Remote Similarity | NPC33996 |
0.6784 | Remote Similarity | NPC136349 |
0.6769 | Remote Similarity | NPC474767 |
0.6768 | Remote Similarity | NPC320818 |
0.6745 | Remote Similarity | NPC21461 |
0.6743 | Remote Similarity | NPC52238 |
0.6739 | Remote Similarity | NPC189261 |
0.6667 | Remote Similarity | NPC328479 |
0.6651 | Remote Similarity | NPC158055 |
0.661 | Remote Similarity | NPC93365 |
0.6538 | Remote Similarity | NPC261595 |
0.6529 | Remote Similarity | NPC315642 |
0.6529 | Remote Similarity | NPC74306 |
0.6512 | Remote Similarity | NPC160666 |
0.651 | Remote Similarity | NPC313514 |
0.6505 | Remote Similarity | NPC326529 |
0.6503 | Remote Similarity | NPC321458 |
0.6503 | Remote Similarity | NPC324033 |
0.6488 | Remote Similarity | NPC62151 |
0.648 | Remote Similarity | NPC195140 |
0.6471 | Remote Similarity | NPC319100 |
0.6471 | Remote Similarity | NPC324198 |
0.6429 | Remote Similarity | NPC71079 |
0.6429 | Remote Similarity | NPC314646 |
0.6417 | Remote Similarity | NPC313897 |
0.6393 | Remote Similarity | NPC324484 |
0.6393 | Remote Similarity | NPC474217 |
0.6378 | Remote Similarity | NPC290959 |
0.6378 | Remote Similarity | NPC326082 |
0.6369 | Remote Similarity | NPC61198 |
0.6359 | Remote Similarity | NPC85918 |
0.6359 | Remote Similarity | NPC325906 |
0.6324 | Remote Similarity | NPC127730 |
0.6324 | Remote Similarity | NPC278366 |
0.6321 | Remote Similarity | NPC62510 |
0.631 | Remote Similarity | NPC262926 |
0.631 | Remote Similarity | NPC89562 |
0.6308 | Remote Similarity | NPC472289 |
0.6292 | Remote Similarity | NPC321052 |
0.6283 | Remote Similarity | NPC317010 |
0.6243 | Remote Similarity | NPC317054 |
0.6229 | Remote Similarity | NPC197068 |
0.6199 | Remote Similarity | NPC30326 |
0.6183 | Remote Similarity | NPC41333 |
0.6171 | Remote Similarity | NPC274384 |
0.6171 | Remote Similarity | NPC89147 |
0.6154 | Remote Similarity | NPC319221 |
0.6146 | Remote Similarity | NPC103388 |
0.6114 | Remote Similarity | NPC211820 |
0.6114 | Remote Similarity | NPC251233 |
0.6114 | Remote Similarity | NPC314491 |
0.6095 | Remote Similarity | NPC324009 |
0.6092 | Remote Similarity | NPC186619 |
0.6083 | Remote Similarity | NPC130570 |
0.608 | Remote Similarity | NPC177169 |
0.6049 | Remote Similarity | NPC276373 |
0.6045 | Remote Similarity | NPC64705 |
0.6045 | Remote Similarity | NPC232408 |
0.604 | Remote Similarity | NPC292361 |
0.6023 | Remote Similarity | NPC318590 |
0.6021 | Remote Similarity | NPC313730 |
0.602 | Remote Similarity | NPC24589 |
0.6019 | Remote Similarity | NPC5802 |
0.601 | Remote Similarity | NPC282458 |
0.601 | Remote Similarity | NPC78941 |
0.6 | Remote Similarity | NPC326694 |
0.599 | Remote Similarity | NPC157821 |
0.5989 | Remote Similarity | NPC317746 |
0.598 | Remote Similarity | NPC149708 |
0.5979 | Remote Similarity | NPC34300 |
0.593 | Remote Similarity | NPC327941 |
0.5909 | Remote Similarity | NPC163421 |
0.5909 | Remote Similarity | NPC188387 |
0.5822 | Remote Similarity | NPC89987 |
0.5816 | Remote Similarity | NPC141377 |
0.5794 | Remote Similarity | NPC320968 |
0.5774 | Remote Similarity | NPC150447 |
0.5767 | Remote Similarity | NPC14590 |
0.5767 | Remote Similarity | NPC471603 |
0.5733 | Remote Similarity | NPC69843 |
0.5728 | Remote Similarity | NPC314957 |
0.5721 | Remote Similarity | NPC64216 |
0.5714 | Remote Similarity | NPC476492 |
0.5707 | Remote Similarity | NPC162268 |
0.568 | Remote Similarity | NPC20593 |
0.5668 | Remote Similarity | NPC54744 |
0.5668 | Remote Similarity | NPC282247 |
0.5665 | Remote Similarity | NPC306397 |
0.5665 | Remote Similarity | NPC75544 |
0.5665 | Remote Similarity | NPC165370 |
0.5662 | Remote Similarity | NPC238945 |
0.5661 | Remote Similarity | NPC124276 |
0.565 | Remote Similarity | NPC325093 |
0.5648 | Remote Similarity | NPC49217 |
0.5641 | Remote Similarity | NPC470498 |
0.5638 | Remote Similarity | NPC120070 |
0.5632 | Remote Similarity | NPC57279 |
0.5625 | Remote Similarity | NPC471322 |
0.5625 | Remote Similarity | NPC469813 |
0.5625 | Remote Similarity | NPC78375 |
0.5625 | Remote Similarity | NPC476446 |
0.5615 | Remote Similarity | NPC469975 |
0.5602 | Remote Similarity | NPC84268 |
0.56 | Remote Similarity | NPC233936 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC125659 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8788 | High Similarity | NPD1046 | Clinical (unspecified phase) |
0.848 | Intermediate Similarity | NPD1063 | Phase 2 |
0.8344 | Intermediate Similarity | NPD527 | Clinical (unspecified phase) |
0.7742 | Intermediate Similarity | NPD5486 | Discontinued |
0.7619 | Intermediate Similarity | NPD5458 | Discontinued |
0.7469 | Intermediate Similarity | NPD249 | Approved |
0.7469 | Intermediate Similarity | NPD250 | Approved |
0.7378 | Intermediate Similarity | NPD195 | Approved |
0.7378 | Intermediate Similarity | NPD186 | Discovery |
0.7365 | Intermediate Similarity | NPD536 | Clinical (unspecified phase) |
0.7344 | Intermediate Similarity | NPD2876 | Phase 3 |
0.7344 | Intermediate Similarity | NPD2877 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD2965 | Clinical (unspecified phase) |
0.7268 | Intermediate Similarity | NPD2824 | Phase 2 |
0.7202 | Intermediate Similarity | NPD283 | Approved |
0.7182 | Intermediate Similarity | NPD4716 | Approved |
0.7143 | Intermediate Similarity | NPD4744 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD185 | Approved |
0.7118 | Intermediate Similarity | NPD338 | Approved |
0.7118 | Intermediate Similarity | NPD1750 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD1369 | Phase 2 |
0.7118 | Intermediate Similarity | NPD242 | Approved |
0.7118 | Intermediate Similarity | NPD3107 | Discontinued |
0.7097 | Intermediate Similarity | NPD207 | Discontinued |
0.7093 | Intermediate Similarity | NPD2624 | Phase 2 |
0.7076 | Intermediate Similarity | NPD339 | Approved |
0.7071 | Intermediate Similarity | NPD4563 | Phase 2 |
0.7065 | Intermediate Similarity | NPD1692 | Approved |
0.7062 | Intermediate Similarity | NPD2647 | Phase 3 |
0.7048 | Intermediate Similarity | NPD166 | Approved |
0.7035 | Intermediate Similarity | NPD169 | Phase 2 |
0.7012 | Intermediate Similarity | NPD193 | Suspended |
0.6994 | Remote Similarity | NPD1732 | Phase 3 |
0.6994 | Remote Similarity | NPD2646 | Discontinued |
0.6959 | Remote Similarity | NPD231 | Clinical (unspecified phase) |
0.6881 | Remote Similarity | NPD8250 | Phase 2 |
0.6872 | Remote Similarity | NPD4459 | Clinical (unspecified phase) |
0.6872 | Remote Similarity | NPD4458 | Phase 2 |
0.6866 | Remote Similarity | NPD2903 | Clinical (unspecified phase) |
0.6866 | Remote Similarity | NPD2902 | Phase 2 |
0.6825 | Remote Similarity | NPD2152 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD216 | Approved |
0.68 | Remote Similarity | NPD218 | Approved |
0.68 | Remote Similarity | NPD217 | Approved |
0.68 | Remote Similarity | NPD219 | Phase 3 |
0.68 | Remote Similarity | NPD220 | Clinical (unspecified phase) |
0.6791 | Remote Similarity | NPD5172 | Phase 2 |
0.6789 | Remote Similarity | NPD2544 | Clinical (unspecified phase) |
0.6784 | Remote Similarity | NPD548 | Clinical (unspecified phase) |
0.678 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD5666 | Phase 2 |
0.6748 | Remote Similarity | NPD4555 | Clinical (unspecified phase) |
0.6722 | Remote Similarity | NPD2135 | Approved |
0.6722 | Remote Similarity | NPD2136 | Approved |
0.6722 | Remote Similarity | NPD2134 | Approved |
0.6697 | Remote Similarity | NPD6351 | Discovery |
0.6651 | Remote Similarity | NPD6840 | Approved |
0.6651 | Remote Similarity | NPD7502 | Clinical (unspecified phase) |
0.6632 | Remote Similarity | NPD2127 | Suspended |
0.6632 | Remote Similarity | NPD2872 | Phase 2 |
0.6629 | Remote Similarity | NPD213 | Clinical (unspecified phase) |
0.6629 | Remote Similarity | NPD214 | Approved |
0.6617 | Remote Similarity | NPD4533 | Clinical (unspecified phase) |
0.661 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD247 | Clinical (unspecified phase) |
0.6529 | Remote Similarity | NPD582 | Approved |
0.651 | Remote Similarity | NPD7138 | Phase 2 |
0.6502 | Remote Similarity | NPD4612 | Discontinued |
0.649 | Remote Similarity | NPD5080 | Phase 2 |
0.6471 | Remote Similarity | NPD4171 | Clinical (unspecified phase) |
0.6467 | Remote Similarity | NPD9582 | Phase 3 |
0.6463 | Remote Similarity | NPD9632 | Phase 3 |
0.6458 | Remote Similarity | NPD3913 | Clinical (unspecified phase) |
0.6458 | Remote Similarity | NPD5684 | Clinical (unspecified phase) |
0.6458 | Remote Similarity | NPD5683 | Clinical (unspecified phase) |
0.6458 | Remote Similarity | NPD5682 | Phase 3 |
0.6458 | Remote Similarity | NPD6417 | Clinical (unspecified phase) |
0.6448 | Remote Similarity | NPD7988 | Suspended |
0.6442 | Remote Similarity | NPD5079 | Phase 2 |
0.6439 | Remote Similarity | NPD4495 | Phase 1 |
0.6436 | Remote Similarity | NPD4683 | Phase 3 |
0.6436 | Remote Similarity | NPD1915 | Phase 1 |
0.6436 | Remote Similarity | NPD1412 | Clinical (unspecified phase) |
0.6429 | Remote Similarity | NPD4239 | Clinical (unspecified phase) |
0.6379 | Remote Similarity | NPD1427 | Clinical (unspecified phase) |
0.6374 | Remote Similarity | NPD3083 | Approved |
0.6373 | Remote Similarity | NPD796 | Phase 2 |
0.6373 | Remote Similarity | NPD8410 | Clinical (unspecified phase) |
0.6369 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6368 | Remote Similarity | NPD4187 | Clinical (unspecified phase) |
0.6364 | Remote Similarity | NPD248 | Discontinued |
0.6359 | Remote Similarity | NPD3014 | Clinical (unspecified phase) |
0.6359 | Remote Similarity | NPD1777 | Approved |
0.6359 | Remote Similarity | NPD3013 | Phase 3 |
0.6359 | Remote Similarity | NPD1776 | Approved |
0.6354 | Remote Similarity | NPD2457 | Phase 2 |
0.6354 | Remote Similarity | NPD2456 | Phase 2 |
0.633 | Remote Similarity | NPD2928 | Phase 2 |
0.6327 | Remote Similarity | NPD5171 | Clinical (unspecified phase) |
0.6304 | Remote Similarity | NPD5925 | Phase 1 |
0.6294 | Remote Similarity | NPD1234 | Discontinued |
0.6289 | Remote Similarity | NPD2591 | Phase 2 |
0.6277 | Remote Similarity | NPD4089 | Clinical (unspecified phase) |
0.6274 | Remote Similarity | NPD534 | Phase 2 |
0.6274 | Remote Similarity | NPD537 | Phase 2 |
0.625 | Remote Similarity | NPD3593 | Approved |
0.625 | Remote Similarity | NPD691 | Discontinued |
0.6239 | Remote Similarity | NPD8375 | Approved |
0.6238 | Remote Similarity | NPD5584 | Clinical (unspecified phase) |
0.6221 | Remote Similarity | NPD549 | Approved |
0.6216 | Remote Similarity | NPD8409 | Suspended |
0.6212 | Remote Similarity | NPD4615 | Phase 2 |
0.6188 | Remote Similarity | NPD5665 | Clinical (unspecified phase) |
0.6184 | Remote Similarity | NPD8371 | Clinical (unspecified phase) |
0.6181 | Remote Similarity | NPD3485 | Clinical (unspecified phase) |
0.6173 | Remote Similarity | NPD3002 | Clinical (unspecified phase) |
0.6168 | Remote Similarity | NPD245 | Suspended |
0.6164 | Remote Similarity | NPD8373 | Clinical (unspecified phase) |
0.6158 | Remote Similarity | NPD2536 | Discontinued |
0.6146 | Remote Similarity | NPD2930 | Clinical (unspecified phase) |
0.6145 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6142 | Remote Similarity | NPD2631 | Clinical (unspecified phase) |
0.6142 | Remote Similarity | NPD2632 | Approved |
0.6142 | Remote Similarity | NPD2630 | Approved |
0.6139 | Remote Similarity | NPD3287 | Clinical (unspecified phase) |
0.6138 | Remote Similarity | NPD1567 | Clinical (unspecified phase) |
0.6124 | Remote Similarity | NPD8321 | Discontinued |
0.6122 | Remote Similarity | NPD6721 | Phase 1 |
0.6122 | Remote Similarity | NPD5757 | Discontinued |
0.6118 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6114 | Remote Similarity | NPD5508 | Phase 1 |
0.6096 | Remote Similarity | NPD5269 | Clinical (unspecified phase) |
0.6096 | Remote Similarity | NPD8291 | Clinical (unspecified phase) |
0.608 | Remote Similarity | NPD6272 | Phase 1 |
0.6078 | Remote Similarity | NPD4599 | Clinical (unspecified phase) |
0.6071 | Remote Similarity | NPD2724 | Phase 1 |
0.6064 | Remote Similarity | NPD1215 | Discontinued |
0.6041 | Remote Similarity | NPD6047 | Phase 1 |
0.6023 | Remote Similarity | NPD174 | Discontinued |
0.6022 | Remote Similarity | NPD2593 | Clinical (unspecified phase) |
0.6021 | Remote Similarity | NPD1599 | Approved |
0.6019 | Remote Similarity | NPD4872 | Clinical (unspecified phase) |
0.6019 | Remote Similarity | NPD3265 | Phase 1 |
0.6011 | Remote Similarity | NPD1333 | Phase 3 |
0.601 | Remote Similarity | NPD3830 | Phase 1 |
0.6009 | Remote Similarity | NPD7202 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD6626 | Approved |
0.6 | Remote Similarity | NPD3521 | Phase 2 |
0.5991 | Remote Similarity | NPD6381 | Phase 2 |
0.599 | Remote Similarity | NPD4999 | Phase 3 |
0.599 | Remote Similarity | NPD2829 | Clinical (unspecified phase) |
0.599 | Remote Similarity | NPD2364 | Suspended |
0.599 | Remote Similarity | NPD4998 | Phase 3 |
0.599 | Remote Similarity | NPD2814 | Clinical (unspecified phase) |
0.5989 | Remote Similarity | NPD1015 | Phase 2 |
0.5989 | Remote Similarity | NPD1016 | Phase 2 |
0.5988 | Remote Similarity | NPD9726 | Discontinued |
0.598 | Remote Similarity | NPD3469 | Phase 3 |
0.598 | Remote Similarity | NPD7504 | Discontinued |
0.5972 | Remote Similarity | NPD6192 | Phase 3 |
0.5971 | Remote Similarity | NPD3831 | Approved |
0.5971 | Remote Similarity | NPD6307 | Clinical (unspecified phase) |
0.5962 | Remote Similarity | NPD5679 | Clinical (unspecified phase) |
0.5961 | Remote Similarity | NPD7935 | Phase 2 |
0.596 | Remote Similarity | NPD3378 | Clinical (unspecified phase) |
0.5953 | Remote Similarity | NPD4893 | Phase 3 |
0.5952 | Remote Similarity | NPD1367 | Phase 2 |
0.5952 | Remote Similarity | NPD2357 | Approved |
0.595 | Remote Similarity | NPD4054 | Clinical (unspecified phase) |
0.5947 | Remote Similarity | NPD2333 | Discontinued |
0.5942 | Remote Similarity | NPD7079 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD5324 | Clinical (unspecified phase) |
0.5938 | Remote Similarity | NPD966 | Clinical (unspecified phase) |
0.5935 | Remote Similarity | NPD6528 | Phase 1 |
0.5933 | Remote Similarity | NPD4023 | Clinical (unspecified phase) |
0.5926 | Remote Similarity | NPD1623 | Approved |
0.5911 | Remote Similarity | NPD1912 | Approved |
0.5907 | Remote Similarity | NPD6772 | Clinical (unspecified phase) |
0.5903 | Remote Similarity | NPD3849 | Clinical (unspecified phase) |
0.5903 | Remote Similarity | NPD2414 | Clinical (unspecified phase) |
0.5895 | Remote Similarity | NPD8412 | Phase 1 |
0.5894 | Remote Similarity | NPD6151 | Phase 2 |
0.5893 | Remote Similarity | NPD5627 | Approved |
0.5892 | Remote Similarity | NPD5358 | Clinical (unspecified phase) |
0.5888 | Remote Similarity | NPD2847 | Phase 2 |
0.5885 | Remote Similarity | NPD2993 | Clinical (unspecified phase) |
0.5882 | Remote Similarity | NPD1705 | Discontinued |
0.588 | Remote Similarity | NPD5465 | Phase 2 |
0.5879 | Remote Similarity | NPD706 | Phase 1 |
0.5879 | Remote Similarity | NPD420 | Discontinued |
0.5877 | Remote Similarity | NPD6992 | Phase 2 |
0.5876 | Remote Similarity | NPD1380 | Discovery |
0.5865 | Remote Similarity | NPD6268 | Phase 1 |
0.5865 | Remote Similarity | NPD6269 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD2445 | Approved |
0.5862 | Remote Similarity | NPD2446 | Approved |
0.5862 | Remote Similarity | NPD2362 | Approved |
0.586 | Remote Similarity | NPD1709 | Phase 1 |
0.586 | Remote Similarity | NPD4074 | Clinical (unspecified phase) |
0.5856 | Remote Similarity | NPD5567 | Approved |
PubChem CID   | 6245 |
ChEMBL   | CHEMBL267099 |
ZINC   |
Molecular Weight:   | 266.10 |
ALogP:   | -2.2791 |
MLogP:   | 1.79 |
XLogP:   | -1.263 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 126.65 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 4 |
# Rings:   | 3 |
# Heavy Atoms:   | 19 |